TET3 and acute myeloid leukemia: In addition, the positive impact of high TET3 expression on OS in cytogenetically normal AML (CN-AML) patients was also validated by Gene Expression Omnibus (GEO) data (GSE12417) via online web tool Genomicscape (Figure 4A–4D).